{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:29:49Z","timestamp":1784917789617,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.euf.2024.12.003","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T15:15:58Z","timestamp":1737558958000},"page":"471-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"11","author":[{"given":"Akihiro","family":"Matsukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi Kardoust","family":"Parizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mancon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Litterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Chlosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2024.12.003_b0005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature","volume":"61","author":"Bud\u00e4us","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/0284186X.2019.1581377","article-title":"Second cancers in radically treated Norwegian prostate cancer patients","volume":"58","author":"Aksness\u00e6ther","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13014-016-0738-z","article-title":"Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis","volume":"12","author":"Hegemann","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bju.15769","article-title":"Risk of severe late toxicity after radiotherapy following radical prostatectomy \u2013 a nationwide study","volume":"130","author":"Braide","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2024.12.003_b0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3857\/roj.2020.00857","article-title":"Risk of second cancer among young prostate cancer survivors","volume":"39","author":"Zhang","year":"2021","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.euf.2024.12.003_b0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s10147-023-02383-1","article-title":"Clinical characteristics of secondary bladder cancer developing after low-\/high-dose-rate brachytherapy to treat localized prostate cancer","volume":"28","author":"Miyajima","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0035","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jjco\/hyw098","article-title":"Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer","volume":"46","author":"Shiota","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2010.09.012","article-title":"Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer","volume":"98","author":"Huang","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.brachy.2021.04.004","article-title":"Ten-year treatment complication outcomes of radical prostatectomy vs external beam radiation vs brachytherapy for 1503 patients with intermediate risk prostate cancer","volume":"20","author":"Goy","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.euf.2024.12.003_b0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/CMAR.S185867","article-title":"High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.euf.2024.12.003_b0055","unstructured":"Dou W, Ren Z, Hu X, et al. Whether pelvic radiotherapy increased the risk of secondary bladder cancer? A systematic review and meta-analysis. Research Square preprint. https:\/\/www.researchsquare.com\/article\/rs-19477\/v1."},{"key":"10.1016\/j.euf.2024.12.003_b0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000356115","article-title":"Radiation-induced secondary malignancy in prostate cancer: a systematic review and meta-analysis","volume":"93","author":"Jin","year":"2014","journal-title":"Urol Int"},{"issue":"492","key":"10.1016\/j.euf.2024.12.003_b0065","first-page":"e1","article-title":"Clinical and histopathological features of bladder cancer following radiotherapy for prostate cancer: a comparative study","volume":"40","author":"Scher\u00f1uk","year":"2022","journal-title":"Urol Oncol"},{"issue":"10","key":"10.1016\/j.euf.2024.12.003_b0070","first-page":"e3","article-title":"Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: a matched cohort analysis","volume":"40","author":"Murthy","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0075","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2021.12.004","article-title":"Genomic features of muscle-invasive bladder cancer arising after prostate radiotherapy","volume":"81","author":"Mossanen","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0080","article-title":"Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A SEER-based study","volume":"24","author":"Natale","year":"2020","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.euf.2024.12.003_b0085","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.juro.2010.01.014","article-title":"Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer","volume":"183","author":"Yee","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.juro.2007.08.157","article-title":"Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy","volume":"179","author":"Bostrom","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euf.2024.12.003_b0100","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2024.12.003_b0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.euf.2024.12.003_b0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0145445516673998","article-title":"Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data","volume":"41","author":"Drevon","year":"2017","journal-title":"Behav Modif"},{"key":"10.1016\/j.euf.2024.12.003_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol."},{"key":"10.1016\/j.euf.2024.12.003_b0120","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2024.12.003_b0125","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2024.12.003_b0130","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/JCO.2011.35.0991","article-title":"Prostate brachytherapy and second primary cancer risk: a competitive risk analysis","volume":"29","author":"Hinnen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0135","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2006.05.016","article-title":"Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up","volume":"66","author":"Liauw","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2024.12.003_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/eb-2018-102911","article-title":"Practical guide to the meta-analysis of rare events","volume":"21","author":"Efthimiou","year":"2018","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.euf.2024.12.003_b0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/M14-1741","article-title":"Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studies","volume":"163","author":"Uno","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euf.2024.12.003_b0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0000000000001232","article-title":"Meta-analysis of proportions using generalized linear mixed models","volume":"31","author":"Lin","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.euf.2024.12.003_b0155","doi-asserted-by":"crossref","first-page":"19647","DOI":"10.1038\/s41598-021-99078-2","article-title":"An efficient and accurate distributed learning algorithm for modeling multi-site zero-inflated count outcomes","volume":"11","author":"Edmondson","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.euf.2024.12.003_b0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00268-005-7916-8","article-title":"Number needed to treat (or harm)","volume":"29","author":"Tram\u00e8r","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.euf.2024.12.003_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1464-410X.2006.06182.x","article-title":"Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer","volume":"98","author":"Sandhu","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2024.12.003_b0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/iju.15373","article-title":"Does intensity-modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score-matched analysis","volume":"31","author":"Tsukuda","year":"2024","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijrobp.2011.08.034","article-title":"Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer","volume":"83","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2024.12.003_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6922","article-title":"Secondary bladder and colorectal cancer after treatments for prostate cancer: a population based study","volume":"13","author":"B\u00e1rcena","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.euf.2024.12.003_b0185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.brachy.2022.03.001","article-title":"Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer","volume":"21","author":"Ozawa","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.euf.2024.12.003_b0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.brachy.2022.04.008","article-title":"Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy","volume":"21","author":"Nakai","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.euf.2024.12.003_b0195","first-page":"209","article-title":"Predictors of secondary bladder cancer in patients with prostate cancer treated with brachytherapy: a single-institution study of a Japanese cohort","volume":"19","author":"Takahara","year":"2021","journal-title":"Urol J"},{"key":"10.1016\/j.euf.2024.12.003_b0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fonc.2021.771956","article-title":"Impact of advanced radiotherapy on second primary cancer risk in prostate cancer survivors: a nationwide cohort study","volume":"11","author":"Jahreiss","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.euf.2024.12.003_b0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.prp.2020.152822","article-title":"Clinical and pathological characteristics of bladder cancer in post brachytherapy patients","volume":"216","author":"Au","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.euf.2024.12.003_b0210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canrad.2017.02.003","article-title":"Second malignancies after permanent implant prostate cancer brachytherapy: a single-institution study of 675 patients treated between 1999 and 2003","volume":"21","author":"Cosset","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.euf.2024.12.003_b0215","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.brachy.2016.06.005","article-title":"The risk of second malignancies after 125I prostate brachytherapy as monotherapy in a single Australian institution","volume":"15","author":"Ots","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.euf.2024.12.003_b0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clon.2014.01.006","article-title":"Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer","volume":"26","author":"Musunuru","year":"2014","journal-title":"Clin Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0225","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s10147-012-0496-3","article-title":"Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy","volume":"18","author":"Okajima","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0230","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ijrobp.2009.02.011","article-title":"The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients","volume":"76","author":"Bhojani","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2024.12.003_b0235","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ijc.23601","article-title":"Increased risk of colon cancer after external radiation therapy for prostate cancer","volume":"123","author":"Rapiti","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euf.2024.12.003_b0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ju.0000163459.57305.a1","article-title":"Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer","volume":"174","author":"Chrouser","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0245","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0022-5347(01)63777-7","article-title":"Second primary malignancies in T1\u20133N0 prostate cancer patients treated with radiation therapy with 10-year followup","volume":"159","author":"Johnstone","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0250","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1464-410X.2012.11385.x","article-title":"Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention","volume":"110","author":"Zelefsky","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2024.12.003_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.584072","article-title":"Risk and prognosis of secondary rectal cancer after radiation therapy for pelvic cancer","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175217","article-title":"Risk of second primary malignancies among patients with prostate cancer: a population-based cohort study","volume":"12","author":"Fan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2024.12.003_b0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.euros.2024.02.013","article-title":"Risk of secondary malignancies after pelvic radiation: a population-based analysis","volume":"63","author":"McPartland","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euf.2024.12.003_b0270","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23025","article-title":"Assessment of second primary cancer risk among men receiving primary radiotherapy vs surgery for the treatment of prostate cancer","volume":"5","author":"Bagshaw","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euf.2024.12.003_b0275","article-title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2024.12.003_b0280","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/biomedicines10102446","article-title":"Ultra-hypofractionated stereotactic body radiotherapy for localized prostate cancer: clinical outcomes, patterns of recurrence, feasibility of definitive salvage treatment, and competing oncological risk","volume":"10","author":"Miszczyk","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.euf.2024.12.003_b0285","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2024.12.003_b0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1667\/RR0527.1","article-title":"Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects","volume":"167","author":"Suit","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.euf.2024.12.003_b0295","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10147-019-01427-9","article-title":"Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer","volume":"24","author":"Guo","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2024.12.003_b0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0305","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00345-019-02982-6","article-title":"Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases","volume":"38","author":"Gontero","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0310","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","article-title":"Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita","volume":"78","author":"Teoh","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.12.003_b0315","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/13685538.2019.1646238","article-title":"Clinical significance of 5-\u03b1 reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review","volume":"23","author":"Kim","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.euf.2024.12.003_b0320","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:32:48Z","timestamp":1762936368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456924002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2405456924002621"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2024.12.003","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}